These results, together with a past report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two support the strategy of targeting ACKR3 as a novel method to modulate the opioid system, which could open new therapeutic avenues for opioid-relevant Issues. In combination with the described over https://anthonyd814fcx3.eedblog.com/profile